Survival outcomes for patients with recurrent low-grade serous ovarian carcinoma

被引：2
|
作者：
Yazigi, A. [1 ,2 ]
Ray-Coquard, I. L. [2 ]
Pujade-Lauraine, E. [3 ,4 ]
Lecuru, F. [5 ]
Bonsang-Kitzis, H. [5 ]
机构：
[1] CHU Toulouse, Toulouse, France
[2] Ctr Leon Berard, Lyon, France
[3] ARCAGY GINECO, Paris, France
[4] Hop Hotel Dieu, Paris, France
[5] Hop Europeen Georges Pompidou, Paris, France
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.05.080
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
192
引用
收藏
页码：93 / 94
页数：2
相关论文
共 50 条
  • [31] Low-Grade Ovarian Serous Neoplasms (Low-Grade Serous Carcinoma and Serous Borderline Tumor) Associated With High-Grade Serous Carcinoma or Undifferentiated Carcinoma: Report of a Series of Cases of an Unusual Phenomenon
    Boyd, Clinton
    McCluggage, W. Glenn
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (03) : 368 - 375
  • [32] SYSTEMATIC REVIEW AND META-ANALYSIS OF THE SURVIVAL IMPACT OF SECONDARY CYTOREDUCTIVE SURGERY FOR RECURRENT LOW-GRADE SEROUS OVARIAN CARCINOMA
    Goldberg, R.
    Kim, R. S.
    Li, X.
    Fazelzad, R.
    Brown, T.
    May, T.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A106 - A106
  • [33] Stage, treatment and survival of low-grade serous ovarian carcinoma in the Netherlands-A nationwide study
    De Decker, Koen
    Wenzel, Hans H. B.
    Bart, Joost
    van der Aa, Maaike A.
    Kruitwagen, Roy F. P. M.
    Nijman, Hans W.
    Kruse, Arnold-Jan
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2023, 102 (03) : 246 - 256
  • [34] A survival analysis comparing women with ovarian low-grade serous carcinoma to those with high-grade histology
    Chen, Ming
    Jin, Ying
    Bi, Yalan
    Yin, Jie
    Wang, Yongxue
    Pan, Lingya
    ONCOTARGETS AND THERAPY, 2014, 7 : 1891 - 1899
  • [35] The genomic landscape of low-grade serous ovarian/peritoneal carcinoma and its impact on clinical outcomes
    Gershenson, David M.
    Sun, Charlotte C.
    Westin, Shannon N.
    Eyada, Mostafa
    Cobb, Lauren P.
    Nathan, Lisa C.
    Sood, Anil K.
    Malpica, Anais
    Hillman, Robert T.
    Wong, Kwong K.
    GYNECOLOGIC ONCOLOGY, 2022, 165 (03) : 560 - 567
  • [36] BORDERLINE AND LOW-GRADE SEROUS OVARIAN CARCINOMA: ANALYSIS OF THE CLINICAL BEHAVIOR IN 151 PATIENTS
    Rotsaert, A.
    Moerman, P.
    Leunen, K.
    Amant, F.
    Neven, P.
    Vergote, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [37] Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
    Santillan, A.
    Kim, Y. W.
    Zahurak, M. L.
    Gardner, G. J.
    Giuntoli, R. L., II
    Shih, I. M.
    Bristow, R. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 601 - 606
  • [38] Trametinib for patients with recurrent low-grade serous ovarian cancer: A cost-effectiveness analysis
    Piao, Huiling
    Wu, Meiyu
    Qin, Shuxia
    Tang, Zhiyao
    Zhou, Guangliang
    Wan, Xiaomin
    Zuo, Xiaocong
    GYNECOLOGIC ONCOLOGY, 2023, 168 : 17 - 22
  • [39] Skin Metastasis of Low-Grade Ovarian Serous Carcinoma: A Case Report
    Ching, Lauren M.
    Tran, Benjamin A.
    Russomanno, Kristen L.
    Cardis, Michael A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (04)
  • [40] Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum
    Gershenson, D.
    Sun, C.
    Iyer, R.
    Wong, K.
    Kavanagh, J.
    Malpica, A.
    Schmeler, K.
    Bodurka, D.
    Deavers, M.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S35 - S35
12345